Back
Corvus Pharmaceuticals Stock Predictions
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
28
CRVS
Corvus Pharmaceuticals
Last Price:
$4.92
Seasonality Move:
-9.57%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.Corvus Pharmaceuticals Stock Forecast
-
Is Corvus Pharmaceuticals Stock Undervalued?The current Corvus Pharmaceuticals [CRVS] share price is $4.90. The Score for CRVS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CRVS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Corvus Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Corvus Pharmaceuticals Stock Rating
Data Unavailable
Corvus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
corvuspharma.com
52-Week Data
52-Week High:
10.00
52-Week Low:
1.30
Prediction Charts
Market Cap:
314.9M
Price in USD:
4.90
Volume:
658.1K
Beta:
1.06
Technical Analysis
SMA50:
7.97
SMA100:
6.29
SMA200:
4.12
52-Wk Change:
188.24%
Stock Predictions
-
Is Corvus Pharmaceuticals stock public?Yes, Corvus Pharmaceuticals is a publicly traded company.
-
What is the Corvus Pharmaceuticals stock quote today?The Corvus Pharmaceuticals stock price is 4.90 USD today.
-
How to buy Corvus Pharmaceuticals stock online?You can buy Corvus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 8.03 | 8.13 | 8.29 | 8.00 |
| Dec-6 | 8.12 | 8.26 | 8.49 | 7.98 |
| Dec-9 | 8.27 | 8.15 | 8.43 | 8.00 |
| Dec-10 | 8.20 | 8.02 | 8.49 | 7.98 |
| Dec-11 | 8.03 | 8.11 | 8.25 | 7.88 |
| Dec-12 | 7.96 | 8.08 | 8.33 | 7.96 |
| Dec-13 | 8.07 | 7.38 | 8.22 | 7.29 |
| Dec-16 | 7.28 | 6.90 | 7.40 | 6.88 |
| Dec-17 | 6.44 | 7.39 | 7.44 | 6.44 |
| Dec-18 | 5.00 | 4.71 | 5.20 | 3.77 |
| Dec-19 | 4.67 | 5.09 | 5.10 | 4.30 |
| Dec-20 | 5.02 | 5.00 | 5.34 | 4.73 |
| Dec-23 | 4.95 | 4.55 | 4.95 | 4.52 |
| Dec-24 | 4.56 | 4.90 | 4.94 | 4.55 |
Corvus Pharmaceuticals Earnings
Data Unavailable
Corvus Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.